Mark Christopher Murray's Insider Trades & SAST Disclosures
Mark Christopher Murray's most recent trade in Celanese Corp - Ordinary Shares - Series A was a trade of 2,353 Common Stock done at an average price of $54.4 . Disclosure was reported to the exchange on March 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mark Christopher Murray.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celanese Corp - Ordinary S... | Mark Christopher Murray | SVP - Acetyls | Purchase of securities on an exchange or from another person at price $ 54.45 per share. | 07 Mar 2025 | 2,353 | 13,989 (0%) | 0% | 54.4 | 128,110 | Common Stock |
| Celanese Corp - Ordinary S... | Mark Christopher Murray | SVP - Acetyls | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 19,027 | 19,027 | - | - | Nonqualified Stock Option (right to buy) | |
| Celanese Corp - Ordinary S... | Mark Christopher Murray | SVP - Acetyls | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 871 | 12,000 (0%) | 0% | 0 | Common Stock | |
| Celanese Corp - Ordinary S... | Mark Christopher Murray | SVP - Acetyls | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.13 per share. | 15 Feb 2025 | 364 | 11,636 (0%) | 0% | 69.1 | 25,163 | Common Stock |
| Celanese Corp - Ordinary S... | Mark Christopher Murray | SVP - Acetyls | Payment of exercise price or tax liability using portion of securities received from the company at price $ 140.58 per share. | 13 Jul 2024 | 471 | 11,129 (0%) | 0% | 140.6 | 66,213 | Common Stock |
| Celanese Corp - Ordinary S... | Mark Christopher Murray | SVP - Acetyls | Purchase of securities on an exchange or from another person at price $ 156.43 per share. | 08 Mar 2024 | 597 | 11,600 (0%) | 0% | 156.4 | 93,389 | Common Stock |
| Celanese Corp - Ordinary S... | Mark Christopher Murray | SVP - Acetyls | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 8,804 | 8,804 | - | - | Nonqualified Stock Option (right to buy) | |
| Celanese Corp - Ordinary S... | Mark Murray Christopher | SVP - Acetyls | Payment of exercise price or tax liability using portion of securities received from the company at price $ 150.82 per share. | 15 Feb 2024 | 124 | 11,003 (0%) | 0% | 150.8 | 18,702 | Common Stock |
| Celanese Corp - Ordinary S... | Mark Christopher Murray | SVP - Acetyls | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.13 per share. | 13 Jul 2023 | 470 | 11,127 (0%) | 0% | 122.1 | 57,401 | Common Stock |
| Celanese Corp - Ordinary S... | Mark Christopher Murray | SVP - Acetyls | Purchase of securities on an exchange or from another person at price $ 101.69 per share. | 12 May 2023 | 1,008 | 11,597 (0%) | 0% | 101.7 | 102,503 | Common Stock |
| Celanese Corp - Ordinary S... | Mark Christopher Murray | SVP - Acetyls | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 8,044 | 8,044 | - | - | Nonqualified Stock Option (right to buy) | |
| Celanese Corp - Ordinary S... | Mark Christopher Murray | SVP - Acetyls | Purchase of securities on an exchange or from another person at price $ 117.15 per share. | 28 Feb 2023 | 1,200 | 10,589 (0%) | 0% | 117.2 | 140,580 | Common Stock |
| Celanese Corp - Ordinary S... | Mark Christopher Murray | SVP - Acetyls | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.56 per share. | 15 Feb 2023 | 124 | 9,389 (0%) | 0% | 121.6 | 15,073 | Common Stock |
| Avantor Inc. | Mark Christopher Murray | EVP, Biomaterials & AT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.50 per share. | 13 Jan 2022 | 918 | 18,680 (0%) | 0% | 37.5 | 34,425 | Common Stock |
| Avantor Inc. | Mark Christopher Murray | EVP, Biomaterials & AT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 26,347 | 26,347 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc. | Mark Christopher Murray | EVP, Biomaterials & AT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 8,140 | 19,598 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc. | Mark Christopher Murray | EVP, Biomaterials & AT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.20 per share. | 13 Jan 2021 | 918 | 11,458 (0%) | 0% | 29.2 | 26,806 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges